CFDA signs ex­clu­sive agree­ment with UL

BioSpectrum (Asia) - - REGULATORY NEWS -

The China Food and Drug Ad­min­is­tra­tion’s In­sti­tute of Ex­ec­u­tive De­vel­op­ment (CF­DAIED) has signed an ex­clu­sive me­moran­dum of un­der­stand­ing (MoU) with UL to de­velop and de­ploy UL’s PURE Learn­ing’s reg­u­la­tory con­tent and train­ing so­lu­tions. Fol­low­ing work to sup­port the CF­DAIED in­spec­tor train­ing pro­gramme, UL and CF­DAIED will jointly create and brand China Food and Drug Ad­min­is­tra­tion (CFDA) reg­u­la­tory cour­ses for use by Life Sci­ence com­pa­nies in China as well as those global Life Sci­ence com­pa­nies look­ing to meet reg­u­la­tory re­quire­ments for prod­ucts im­ported into China.

This agree­ment will en­sure long-term ex­clu­sive co­op­er­a­tion for at least the next five years. The co­op­er­a­tion with CF­DAIED will help pro­mote UL’s brand aware­ness in China, raise UL’s pro­file among man­u­fac­tur­ers in the Life Sci­ence in­dus­try, and help Chi­nese au­thor­i­ties im­prove and scale their in­spec­tor train­ing pro­grammes.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.